Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/2008
03/25/2008CA2319217C Pharmaceutical compositions
03/25/2008CA2315835C New crystalline form of 1-methyl-5-p-toluoylpyrrole-2-acetamidoacetic acid guaiacyl ester
03/25/2008CA2299308C Cyclohexenone long-chain alcohol and medicament containing same
03/25/2008CA2295455C Process for the preparation of mometasone furoate
03/25/2008CA2291796C Therapeutically active compositions
03/25/2008CA2277273C Integrin antagonists
03/25/2008CA2275153C Pharmaceutical compositions for freeze drying
03/25/2008CA2268709C Hiv protease inhibitors
03/25/2008CA2268394C New heterocyclylmethyl-substituted pyrazol derivates
03/25/2008CA2264822C Cocoa components, edible products having enhanced polyphenol content, methods of making same and medical uses
03/25/2008CA2250002C Cephem compounds and drugs containing the compounds
03/25/2008CA2243578C High affinity nucleic acid ligands of complement system proteins
03/25/2008CA2228281C Use of l-carnitine and acyl l-carnitines for lowering ceramide levels
03/25/2008CA2203652C A method of down-regulating gene expression
03/25/2008CA2189984C P75 tnf receptor promoters
03/25/2008CA2174707C Chromone derivatives as nk1 and substance p antagonists
03/25/2008CA2173493C Fused pyridazine compounds
03/25/2008CA2173319C Radiation sensitization using texaphyrins
03/25/2008CA2164642C Novel compounds having a benzisoselen-azoline and -azine structure, method for preparing same and therapeutic uses thereof
03/25/2008CA2073500C Compositions and methods for detecting and modulating rna activity and gene expression
03/20/2008WO2008034142A2 Synthesis, methods of using, and compositions of cycloalkylmethylamines
03/20/2008WO2008034129A2 Treatment of cancer or obesity with conjugated linoleic acids
03/20/2008WO2008034124A2 Targeted polymeric prodrugs containing multifunctional linkers
03/20/2008WO2008034119A2 Polyalkylene oxides having hindered ester-based biodegradable linkers
03/20/2008WO2008034087A2 Treating schizophrenia with combinations of levodopa and an antipsychotic agent
03/20/2008WO2008034076A2 Cyclophosphamide in combination with immune therapeutics
03/20/2008WO2008034074A2 Cyclosphosphamide in combination with anti-idiotypic vaccines
03/20/2008WO2008034041A2 Therapeutic combinations
03/20/2008WO2008034040A1 Topiramate compositions and methods for their use
03/20/2008WO2008034039A2 Novel tetrahydro-isoquinolines
03/20/2008WO2008034011A2 Methods of modulating cell proliferation and cyst formation in polycystic kidney and liver diseases
03/20/2008WO2008034008A2 Kinase inhibitors useful for the treatment of proliferative diseases
03/20/2008WO2008033999A2 Kinase inhibitors useful for the treatment of proliferative diseases
03/20/2008WO2008033956A2 Macrocyclic lactone compounds and methods for their use
03/20/2008WO2008033935A2 Vinorelbine derivatives
03/20/2008WO2008033934A1 Substituted heteroaryl carboxylic acid derivatives as ptb-1b inhibitors
03/20/2008WO2008033932A2 Biarylthiazole carboxylic acid derivatives as protein tyrosine phosphatase-ib inhibitors
03/20/2008WO2008033930A2 Vinca derivatives
03/20/2008WO2008033894A2 Compounds with activity at estrogen receptors
03/20/2008WO2008033858A2 Kinase inhibitors, and methods of using and identifying kinase inhibitors
03/20/2008WO2008033854A1 Certain substituted amides, method of making, and method of use thereof
03/20/2008WO2008033851A2 Use of 2-6- (3-amino-piperidin-l-yl) -3-methyl-2, 4-dioxo-3, 4-dihydr0-2h-pyrimidin-1-ylmet hyl-4-fluoro-benzonitrile
03/20/2008WO2008033834A1 Pyrimidines derivatives and their use as kinase inhibitors
03/20/2008WO2008033807A2 Synergistic combinations of antineoplastic thiol-binding mitochondrial oxidants and antineoplastic proteasome inhibitors for the treatment of cancer
03/20/2008WO2008033798A2 A pyrrolopyrazin as syk-kinase inhibitor
03/20/2008WO2008033764A2 Quinazolinone and isoquinolinone acetamide derivatives
03/20/2008WO2008033757A2 2-(1-oxo-1h-isoquinolin-2-yl) acetamide derivatives
03/20/2008WO2008033754A2 Xanthine derivatives in methods and compositions for the treatment of vascular depression
03/20/2008WO2008033749A2 Quinazoline based egfr inhibitors containing a zinc binding moiety
03/20/2008WO2008033748A2 Quinazoline based egfr inhibitors containing a zinc binding moiety
03/20/2008WO2008033747A2 Multi-functional small molecules as anti-proliferative agents
03/20/2008WO2008033746A2 Tyrosine kinase inhibitors containing a zinc binding moiety
03/20/2008WO2008033745A2 Fused bicyclic pyrimidines as ptk inhibitors containing a zinc binding moiety
03/20/2008WO2008033743A1 Substituted 2-indolinone as ptk inhibitors containing a zinc binding moiety
03/20/2008WO2008033739A2 Benzimidazole carboxamide derivatives
03/20/2008WO2008033655A2 Compositions and methods for treating, controlling, reducing, ameliorating, or preventing allergy
03/20/2008WO2008033643A2 Treatment of non-hodgkin's lymphomas with multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamptothecin
03/20/2008WO2008033572A1 Acyloxyalkyl carbamate prodrugs, methods of synthesis and use
03/20/2008WO2008033567A1 N-methylaminomethyl isoindole compounds and compositions comprising and methods of using the same
03/20/2008WO2008033564A1 Compounds for modulating trpv3 function
03/20/2008WO2008033548A2 System and methods of melanoma prevention
03/20/2008WO2008033545A2 Triphenylphosphine oxide derivatives and uses thereof
03/20/2008WO2008033543A2 Halogenated alkyl di- and trisaccharides, pharmaceutical formulations, diagnostic kits and methods of treatment
03/20/2008WO2008033523A1 Abuse resistant drug formulation
03/20/2008WO2008033513A1 ISOXAZOLINE ALPHA 1a/1d ADRENORECEPTOR ANTAGONISTS
03/20/2008WO2008033468A2 Azetidine and azetidone derivatives useful in treating pain and disorders of lipid metabolism
03/20/2008WO2008033466A2 Compositions and methods for treatment of viral diseases
03/20/2008WO2008033465A1 Azetidinone derivatives and methods of use thereof
03/20/2008WO2008033460A2 Treating pain, diabetes, and lipid metabolism disorders
03/20/2008WO2008033456A1 Spiro-condensed azetidine derivatives useful in treating pain, diabetes and disorders of lipid metabilism
03/20/2008WO2008033449A2 Compounds for the treatment of angiogenesis
03/20/2008WO2008033447A1 Azetidine and azetidone derivatives useful in treating pain and disorders of lipid metabolism
03/20/2008WO2008033444A2 Anti-apoptotic benzodiazepine receptor ligand inhibitors
03/20/2008WO2008033440A2 Treatment of hyperproliferative diseases with anthraquinones
03/20/2008WO2008033432A2 Immune modulation by chemically modified ribonucleosides and oligoribonucleotides
03/20/2008WO2008033431A1 Spirocyclic azetidinone derivatives for the treatment of disorders of lipid metabolism, pain, diabetes and other disorders
03/20/2008WO2008033427A2 Compositions and methods for detection of lysosomal storage disease
03/20/2008WO2008033375A2 Long lasting drug formulations
03/20/2008WO2008033365A2 Amino ion releasing hydrogen bonded molecule
03/20/2008WO2008033352A2 Monocarboxylates for modifying macrophage function
03/20/2008WO2008033308A2 Control of malignant cells proliferation through the inhibition of casein kinase 2
03/20/2008WO2008033305A2 Automatic emergency call notification to pre-designated personal emergency contacts
03/20/2008WO2008033300A2 Bis (thiohydrazide amides) formulation
03/20/2008WO2008033299A2 Use of n-containing spirocompounds for the enhancement of cognitive function
03/20/2008WO2008033125A1 Methods of treatment for ulcerative colitis using aminosalicylate
03/20/2008WO2008033124A1 Methods of treatment for ulcerative colitis
03/20/2008WO2008033041A1 Cancer treatment
03/20/2008WO2008033040A1 Combination approaches to cancer treatment
03/20/2008WO2008033039A1 Cancer treatment
03/20/2008WO2008033024A2 Dosage unit for sublingual, buccal or oral administration of water-insoluble pharmaceutically active substances
03/20/2008WO2008032876A1 Preventive or remedy for er-negative and her2-negative breast cancer and method of screening the same
03/20/2008WO2008032858A2 Thiadiazole compound and use thereof
03/20/2008WO2008032817A1 Sugar chain having activity against helicobacter pylori
03/20/2008WO2008032814A1 Aspirin-containing pharmaceutical agent
03/20/2008WO2008032777A1 Antibacterial peptide and use thereof
03/20/2008WO2008032764A1 Fused heterocyclic derivative
03/20/2008WO2008032726A1 Solid pharmaceutical composition for oral administration comprising optically stable ramosetron
03/20/2008WO2008032719A1 Adhesive preparation
03/20/2008WO2008032718A1 Adhesive preparation
03/20/2008WO2008032696A1 Preventive or therapeutic agent for respiratory disease
1 ... 3329 3330 3331 3332 3333 3334 3335 3336 3337 3338 3339 3340 3341 3342 3343 3344 3345 3346 3347 3348 3349 ... 7860